PHARMExcel is an award-winning, full-service Contract Research Organization (CRO) providing a flexible and innovative approach to clinical trial delivery.
The company offers in-depth knowledge and experience of the clinical research environment, particularly in the UK, and has a network of regulatory, and other industry associates, allowing us to provide a global reach.
Resolution Therapeutics is a biotechnology company developing macrophage cell therapy to treat inflammatory organ disease. The company was founded following a productive collaboration between Edinburgh’s Centre for Regenerative Medicine, the Scottish National Blood Transfusion Service, and Syncona Investment Management Limited. The company is based in the Centre for Regenerative Medicine on the Edinburgh Royal Infirmary Campus, and is backed by Syncona.
The Emmes Company is a global, full-service CRO advancing human health through scientific rigor and integrity.
Emmes is dedicated to helping commercial, government, non-profit and academic partners achieve their biopharmaceutical development and human health goals. Emmes’ commitment to scientific excellence, collaboration, and problem-solving, helps our clients better understand complex research problems, generate higher quality data, and make better treatment options available to patients. These qualities are what enable us to stand above other clinical research companies.